Valuation Edwards Lifesciences Corporation
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
01:30:03 01/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 90.75 USD | +0.60% |
|
+0.28% | +6.45% |
Company Valuation: Edwards Lifesciences Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,883 | 46,128 | 46,246 | 43,663 | 49,471 | 52,308 | - | - |
| Change | - | -42.97% | 0.25% | -5.58% | 13.3% | 5.74% | - | - |
| Enterprise Value (EV) 1 | 80,616 | 45,956 | 45,198 | 40,285 | 45,843 | 48,677 | 47,114 | 45,298 |
| Change | - | -42.99% | -1.65% | -10.87% | 13.8% | 6.18% | -3.21% | -3.85% |
| P/E | 54.4x | 30.6x | 33.2x | 10.6x | 46.6x | 35.9x | 27.5x | 24.4x |
| PBR | 13.9x | 7.82x | 6.99x | 4.36x | 4.79x | 4.93x | 4.29x | 3.98x |
| PEG | - | 12.14x | -5.79x | 0x | -0.6x | 0.9x | 0.9x | 1.9x |
| Capitalization / Revenue | 15.5x | 8.57x | 7.7x | 8.03x | 8.15x | 7.74x | 7.04x | 6.4x |
| EV / Revenue | 15.4x | 8.54x | 7.53x | 7.41x | 7.56x | 7.2x | 6.34x | 5.54x |
| EV / EBITDA | 46.6x | 23.7x | 24.1x | 24.1x | 25.5x | 22.8x | 19.8x | 16.9x |
| EV / EBIT | 50.6x | 25.6x | 26.1x | 26.6x | 27.9x | 24.7x | 21.3x | 18.2x |
| EV / FCF | 57.3x | 47.2x | 47.9x | 139x | 34.3x | 57.3x | 29.3x | 24.9x |
| FCF Yield | 1.74% | 2.12% | 2.09% | 0.72% | 2.91% | 1.74% | 3.42% | 4.01% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.38 | 2.44 | 2.3 | 6.97 | 1.83 | 2.531 | 3.304 | 3.718 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 5,232 | 5,382 | 6,005 | 5,440 | 6,068 | 6,759 | 7,429 | 8,177 |
| EBITDA 1 | 1,729 | 1,936 | 1,879 | 1,670 | 1,800 | 2,137 | 2,384 | 2,687 |
| EBIT 1 | 1,594 | 1,796 | 1,734 | 1,514 | 1,644 | 1,971 | 2,212 | 2,484 |
| Net income 1 | 1,503 | 1,522 | 1,402 | 4,175 | 1,074 | 1,435 | 1,897 | 2,121 |
| Net Debt 1 | -267 | -172.7 | -1,048 | -3,378 | -3,628 | -3,631 | -5,195 | -7,011 |
| Reference price 2 | 129.55 | 74.61 | 76.25 | 74.03 | 85.25 | 90.75 | 90.75 | 90.75 |
| Nbr of stocks (in thousands) | 6,24,334 | 6,18,260 | 6,06,500 | 5,89,800 | 5,80,300 | 5,76,400 | - | - |
| Announcement Date | 26/01/22 | 31/01/23 | 06/02/24 | 11/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 35.86x | 7.2x | 22.78x | -.--% | 5.23TCr | ||
| 30.73x | 5.43x | 20.81x | 0.3% | 23TCr | ||
| 36.02x | 6.47x | 20.52x | 0.67% | 15TCr | ||
| 41.34x | 10.75x | 23.77x | -.--% | 13TCr | ||
| 18.03x | 3.68x | 11.96x | -.--% | 7TCr | ||
| 19.39x | 2.33x | 11.66x | 2.64% | 5.06TCr | ||
| 29.92x | 5.83x | 19.86x | 0.67% | 4.33TCr | ||
| 72.59x | 6.92x | 21.08x | -.--% | 4.07TCr | ||
| 20.84x | 5.79x | 14.95x | 1.11% | 3.46TCr | ||
| 43.16x | 7.03x | 24.8x | -.--% | 3.23TCr | ||
| Average | 34.79x | 6.14x | 19.22x | 0.54% | 8.35TCr | |
| Weighted average by Cap. | 34.01x | 6.41x | 19.93x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EW Stock
- Valuation Edwards Lifesciences Corporation
Select your edition
All financial news and data tailored to specific country editions
















